These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2664857)

  • 1. [Prognosis and therapy of malignant non-Hodgkin's lymphoma].
    Brockmann B; Riessbeck KH
    Radiobiol Radiother (Berl); 1989; 30(2):101-6. PubMed ID: 2664857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent progress in the treatment of malignant lymphoma].
    Ogura M
    Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medicinal therapy of malignant lymphomas].
    Aul C; Schroeder M; Giagounidis A
    Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the management of non-Hodgkin's lymphomas.
    Gaynor ER; Fisher RI
    Dis Mon; 1989 Sep; 35(9):597-650. PubMed ID: 2676434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical aspects and prognosis of highly malignant non-Hodgkin's lymphomas].
    Rohrberg R; Krug K; Krahl D; Doering G; Kujat G; Heider KM; Hesse A; Roedel G; Stenzel L
    Z Gesamte Inn Med; 1986 Oct; 41(19):528-33. PubMed ID: 3811439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy for non-Hodgkin's lymphoma].
    Kuraishi Y; Usui N; Dobashi N
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2210-6. PubMed ID: 9881077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
    Zhou SY; Shi YK; He XH; Zhang P; Dong M; Huang DZ; Yang JL; Zhang CG; Liu P; Yang S; Feng FY
    Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
    Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
    J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of high risk non-Hodgkin's lymphoma].
    Sawada U
    Rinsho Ketsueki; 1993 Apr; 34(4):403-10. PubMed ID: 7685431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    Laport GF; Williams SF
    Semin Oncol; 1998 Aug; 25(4):503-17. PubMed ID: 9728600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
    van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
    J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sequential polychemotherapy and large-field radiotherapy of non-Hodgkin's lymphoma].
    Kuse R; Heilmann HP; Calavrezos A; Hausmann K
    Strahlentherapie; 1985 Apr; 161(4):231-8. PubMed ID: 3922093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress in the chemotherapy of malignant lymphoma].
    Tobinai K
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):437-43. PubMed ID: 7887635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
    Bernard M; Cartron G; Rachieru P; LeMevel A; Branger B; Le Maignan C; Berthou C; Ghandour C; Delwail V; Milpied N; Cassasus P; Celigny PS; Guyotat D; Lamy T; Desablens B;
    Haematologica; 2005 Jun; 90(6):802-9. PubMed ID: 15951293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.